Upper gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs in African-American and hispanic elderly patients

Ethnicity and Disease

Volumn 13, Issue 4, 2003, Pages 528-533

  Akhtar, Abbasi J ^a,b   Shaheen, Magda ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b KING DREW MEDICAL CENTER   (United States)

Author keywords

African American; Anti inflammatory; Elderly; Gastrointestinal; Hispanic; Nonsteroidal

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2 INHIBITOR; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ABDOMINAL PAIN; AGED; ARTICLE; ASIAN; CAUCASIAN; CONTROLLED STUDY; DATA ANALYSIS; DEATH; DISEASE ASSOCIATION; DRUG MONITORING; DRUG USE; ENDOSCOPIC THERAPY; ENDOSCOPY; ESOPHAGUS STRICTURE; ETHNIC GROUP; ETHNOLOGY; FEMALE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SURGERY; GASTROINTESTINAL TOXICITY; HELICOBACTER PYLORI; HISPANIC; HUMAN; IATROGENIC DISEASE; INTESTINE ULCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORBIDITY; MORTALITY; NEGRO; PEPTIC ULCER; REFLUX ESOPHAGITIS; RETROSPECTIVE STUDY; RISK; STATISTICAL ANALYSIS; STOMACH EROSION; STOMACH ULCER; SYMPTOM; URBAN POPULATION;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; GASTROINTESTINAL DISEASES; GASTROINTESTINAL HEMORRHAGE; HISPANIC AMERICANS; HUMANS; MALE; ODDS RATIO; RETROSPECTIVE STUDIES; URBAN POPULATION;

EID: 0242575136     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. McCarthy D. Nonsteroidal anti-inflammatory drug-related gastrointestinal toxicity: definitions and epidemiology. Am J Med. 1998; 105:3S-9S.
2. El-Serag HB, Sonnenberg A. Association of esophagitis and esophageal strictures with diseases treated with nonsteroidal anti-inflammatory drugs. Am J Gasteroenterol. 1997;92: 52-56.
3. Smalley WE, Ray WA, Daugherty JR, Griffin MR. Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons. Am J Epidemiol. 1995;141:539-545.
4. Griffin MR, Ray WA, Schaffner WS. Non-steroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. Ann Intern Med. 1988;109:359-363.
5. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. N Engl J Med. 1999;340: 1888-1899.
6. Scheiman JM. NSAIDs, gastrointestinal injury and cytoprotection. Gastroentrol Clin North Am. 1996;25:279-298.
7. Kawano S, Tsuji S, Sato N, Kamada T. NSAIDs and the microcirculation of the stomach. Gastroenterol Clin North Am. 1996; 25:299-315.
8. Blower AL, Brooks A, Fenn GC, et al. Emergency admissions for upper gastrointestinal disease and their relation to NSAID use. Aliment Pharmacol Ther. 1997;11:283-291.
9. Aabakken L. Clinical symptoms, endoscopic findings, and histologic features of gastroduodenal non-steroidal anti-inflammatory drugs lesions. Ital J Gastroenterol Hepatol. 1999;31: S19-S22.
10. Bjorkman DJ. Nonsteroidal anti-inflammatory drug-induced gastroduodenal injury. Am J Med. 1996;101:25S-32S.
11. Lanas A, Hirschowitz BI. Toxicity of NSAIDs in the stomach and duodenum. Eur J Gastoenterol Hepatol. 1999;11:375-381.
12. Wallace JL. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years. Gastroenterology. 1997;112:1000-1016.
13. Duggan JM, Dobson AJ, Johnson H, Fahey P. Peptic ulcer and non-steroidal anti-inflammatory agents. Gut. 1986;27:929-933.
14. Akhtar AJ, Ganesan K, Yoshikawa TT. Upper gastrointestinal hemorrhage in African-American and Hispanic elderly patients. Ethn Dis. 2001;11:7-10.
15. Skander MP, Ryan FP. Non-steroidal anti-inflammatory drugs and pain free peptic ulceration in the elderly. Br Med J. 1988;833-834.
16. Akhtar AJ, Boyapalli RR, Yoshikawa TT. Extraintestinal presentations of gastrointestinal hemorrhage in elderly patients of a minority population. Nurs Home Med. 1997;5:299-301.
17. Collen MJ, Abdulian JD. Do non-steroidal anti-inflammatory drugs cause duodenal ulcer? Evaluation of basal acid output and ulcer complications. J Gastroenterol Hepatol. 1996; 11:520-523.
18. Chan FK, To KF, Wu JC, et al. Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomized trial. Lancet. 2002;359:9-13.
19. Everhart JE, Kruszon-Moran D, Perez-Perez GI, et al. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis. 2000; 181:1359-1363.
20. Rothenbacher D, Bode G, Peschke F, et al. Active infection with Helicobacter pylori in an asymptomatic population of middle-aged to elderly people. Epidemiol Infect. 1998;120: 297-303.
21. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med. 1991;115:787-796.
22. Lanas A, Serrano P, Bajador E, et al. Evidence of aspirin use in both upper and lower gastrointestinal perforation. Gastroenterology. 1997;112:683-689.
23. Naesdal J, Wilson I. Gastro-duodenal protection in an era of cyclo-oxygenase-2-selective nonsteroidal anti-inflammatory drugs. Eur J Gastroenterol Hepatol. 2001;13:1401-1406.
24. Graham DY, Agrawal NM, Campbell DR, et al. Ulcer prevention in long-term users of non-steroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole. Arch Intern Med. 2002;162:169-175.
25. Griffin MR, Scheiman JM. Prospects for changing the burden of nonsteroidal anti-inflammatory drug toxicity. Am J Med. 2001; 110:33S-37S.